Efficacy and Safety Study on bIAP

NCT01010724 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery

Interventions

DRUG: bIAP
DRUG: Placebo

Sponsor

Catharina Ziekenhuis Eindhoven

Collaborators

[object Object]